Cargando…
The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients
It is estimated that in the past two decades the number of patients diagnosed with diabetes mellites (DM) has doubled. Despite significant progress in the treatment of cardiovascular disease (CVD), including novel anti-platelet agents, effective lipid-lowering medications, and advanced revasculariza...
Autores principales: | Mazin, Israel, Chernomordik, Fernando, Fefer, Paul, Matetzky, Shlomi, Beigel, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000034/ https://www.ncbi.nlm.nih.gov/pubmed/35407513 http://dx.doi.org/10.3390/jcm11071904 |
Ejemplares similares
-
The burden of heart failure in cardiac intensive care unit: a prospective 7 years analysis
por: Grupper, Avishay, et al.
Publicado: (2023) -
Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018) -
Reply to Čulić et al—COVID-19 Pandemic and Possible Rebound Phenomenon in Incidence of Acute Myocardial Infarction
por: Fardman, Alexander, et al.
Publicado: (2021) -
Pericardial Involvement in ST-Segment Elevation Myocardial Infarction as Detected by Cardiac MRI
por: Massalha, Eias, et al.
Publicado: (2022) -
Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging
por: Massalha, Eias, et al.
Publicado: (2022)